Seki N - Search Results

1

Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.

Okabe M, Toh U, Iwakuma N, Saku S, Akashi M, Kimitsuki Y, Seki N, Kawahara A, Ogo E, Itoh K, Akagi Y. Okabe M, et al. Among authors: seki n. Cancer Sci. 2017 Jan;108(1):81-90. doi: 10.1111/cas.13114. Epub 2017 Jan 21. Cancer Sci. 2017. PMID: 27801993 Free PMC article.

2

Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.

Seki N, Toh U, Sayers TJ, Fujii T, Miyagi M, Akagi Y, Kusukawa J, Kage M, Shirouzu K, Yamana H. Seki N, et al. Mol Cancer Ther. 2010 Jun;9(6):1842-51. doi: 10.1158/1535-7163.MCT-09-0918. Epub 2010 Jun 1. Mol Cancer Ther. 2010. PMID: 20515944 Free PMC article.

3

Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy.

Takahashi R, Toh U, Iwakuma N, Mishima M, Fujii T, Takenaka M, Koura K, Seki N, Kawahara A, Kage M, Ogo E, Shirouzu K. Takahashi R, et al. Among authors: seki n. Exp Ther Med. 2013 Nov;6(5):1089-1095. doi: 10.3892/etm.2013.1289. Epub 2013 Sep 6. Exp Ther Med. 2013. PMID: 24223627 Free PMC article.

4

FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.

Takenaka M, Seki N, Toh U, Hattori S, Kawahara A, Yamaguchi T, Koura K, Takahashi R, Otsuka H, Takahashi H, Iwakuma N, Nakagawa S, Fujii T, Sasada T, Yamaguchi R, Yano H, Shirouzu K, Kage M. Takenaka M, et al. Among authors: seki n. Mol Clin Oncol. 2013 Jul;1(4):625-632. doi: 10.3892/mco.2013.107. Epub 2013 Apr 26. Mol Clin Oncol. 2013. PMID: 24649219 Free PMC article.

5

Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.

Takahashi R, Toh U, Iwakuma N, Takenaka M, Otsuka H, Furukawa M, Fujii T, Seki N, Kawahara A, Kage M, Matsueda S, Akagi Y, Yamada A, Itoh K, Sasada T. Takahashi R, et al. Among authors: seki n. Breast Cancer Res. 2014 Jul 3;16(4):R70. doi: 10.1186/bcr3685. Breast Cancer Res. 2014. PMID: 24992895 Free PMC article. Clinical Trial.

6

Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion.

Toh U, Fujii T, Seki N, Niiya F, Shirouzu K, Yamana H. Toh U, et al. Among authors: seki n. Cancer Immunol Immunother. 2006 Oct;55(10):1219-27. doi: 10.1007/s00262-005-0112-8. Epub 2005 Dec 16. Cancer Immunol Immunother. 2006. PMID: 16362409 Free PMC article.

7

[The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer].

Toh U, Fujii T, Tayama K, Yanaga H, Yokoyama G, Yamaguchi M, Horiuchi H, Sasatomi T, Takamori S, Shirouzu K, Seki N, Yamana H. Toh U, et al. Among authors: seki n. Gan To Kagaku Ryoho. 2004 Oct;31(11):1649-51. Gan To Kagaku Ryoho. 2004. PMID: 15553672 Clinical Trial. Japanese.

8

Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways.

Seki N, Toh U, Kawaguchi K, Ninomiya M, Koketsu M, Watanabe K, Aoki M, Fujii T, Nakamura A, Akagi Y, Kusukawa J, Kage M, Shirouzu K, Yamana H. Seki N, et al. J Cell Biochem. 2012 Jul;113(7):2346-55. doi: 10.1002/jcb.24107. J Cell Biochem. 2012. PMID: 22359269

9

YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cells.

Fujii T, Seki N, Namoto-Matsubayashi R, Takahashi H, Inoue Y, Toh U, Kage M, Shirouzu K. Fujii T, et al. Among authors: seki n. Future Oncol. 2009 Mar;5(2):153-6. doi: 10.2217/14796694.5.2.153. Future Oncol. 2009. PMID: 19284373

10

A polymorphism of the 5' flanking region of tumour necrosis factor α gene is associated with thyroid-associated ophthalmopathy in Japanese.

Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K. Kamizono S, et al. Among authors: seki n. Clin Endocrinol (Oxf). 2000 Jun;52(6):759-764. doi: 10.1046/j.1365-2265.2000.01011.x. Clin Endocrinol (Oxf). 2000. PMID: 28796351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,051 results

Search Page